The expanding menagerie: Animal models of hemophilia A

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 11, 2010, Pages 2469-2471

  Monahan, P E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; GLUTAMINE; HISTIDINE; LEUCINE; MESSENGER RNA; PROLINE; REAGENT;

BREEDING; DRUG EFFICACY; EXPERIMENTAL ANIMAL; EXPERIMENTAL DOG; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXPERIMENTAL PIG; EXPERIMENTAL RAT; GENE MUTATION; GENE THERAPY; GENETIC ENGINEERING; HEMARTHROSIS; HEMOPHILIA A; HISTORY; IMMUNOLOGICAL TOLERANCE; INHERITANCE; INVESTMENT; KNOCKOUT MOUSE; MEDICAL RESEARCH; MISSENSE MUTATION; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PHARMACODYNAMICS; PHARMACOKINETICS; PHENOTYPE; PLASMA VOLUME; PRIORITY JOURNAL; SHEEP; SPONTANEOUS MUTATION; SYNOVIAL FLUID; TARGETED GENE REPAIR; UNITED KINGDOM;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; MICE; MUTATION; RATS; SHEEP;

EID: 78149241959     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.04053.x     Document Type: Note

References (16)

1. Graham JB, Brinkhous KM, Dodds WJ. Canine and equine hemophilia. In: Brinkhous KM, Hemker HC, eds. Handbook of Hemophilia. Amsterdam: Excerpta Medica, 1975: 119-39.
2. Nichols TC, Dillow AM, Franck HW, Merricks EP, Raymer RA, Bellinger DA, Arruda VR, High KA. Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency. ILAR J 2009; 50: 144-67.
3. m1Ycb rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A. J Thromb Haemost 2010; 8: 2472-7.
4. Booth CJ, Brooks MB, Rockwell S. Spontaneous coagulopathy in inbred WAG/RijYcb rats. Comp Med 2010; 60: 25-30.
5. Porada CD, Sanada C, Long CR, Wood JA, Desai J, Frederick N, Millsap L, Bormann C, Menges SL, Hanna C, Flores-Foxworth G, Shin T, Westhusin ME, Liu W, Glimp H, Zanjani ED, Lozier JN, Pliska V, Stranzinger G, Joerg H, et al. Clinical and molecular characterization of a re-established line of sheep exhibiting hemophilia A. J Thromb Haemost 2010; 8: 276-85.
6. Pipe SW, Saenko EL, Eickhorst AN, Kemball-Cook G, Kaufman RJ. Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood 2001; 97: 685-91.
7. Nath SV, Williams VK, Griffiths AB, Revesz T. Discrepancy in factor VIII 1-stage/2-stage activity in a child with Arg(531) - > His mutation. Blood Coagul Fibrinolysis 2010; 21: 474-5.
8. Lin HF, Maeda N, Smithies O, Straight DL, Stafford DW. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 1997; 90: 3962-6.
9. Watzka M, Geisen C, Seifried E, Oldenburg J. Sequence of the rat factor VIII cDNA. Thromb Haemost 2004; 91: 38-42.
10. Elder B, Lakich D, Gitschier J. Sequence of the murine factor VIII cDNA. Genomics 1993; 16: 374-9. S0888-7543(83)71200-0.
11. Cameron C, Notley C, Hoyle S, McGlynn L, Hough C, Kamisue S, Giles A, Lillicrap D. The canine factor VIII cDNA and 5′flanking sequence. Thromb Haemost 1998; 79: 317-22.
12. Rawle FE, Lillicrap D. Preclinical animal models for hemophilia gene therapy: predictive value and limitations. Semin Thromb Hemost 2004; 30: 205-13.
13. Monahan PE, Lothrop CD, Sun J, Hirsch ML, Kafri T, Kantor B, Sarkar R, Tillson DM, Elia JR, Samulski RJ. Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application. Mol Ther 2010; doi:.
14. Reinwald S, Burr D. Review of nonprimate, large animal models for osteoporosis research. J Bone Miner Res 2008; 23: 1353-68.
15. Sun J, Hakobyan N, Valentino LA, Feldman BL, Samulski RJ, Monahan PE. Intra-articular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX. Blood 2008; 112: 4532-41.
16. 593 to Cys substitution. Thromb Haemost 2006; 95: 341-47.